FDA has conducted inspections of several hospitals—including Brigham & Women's Hospital—based on allegations that physicians and administrators did not report patient harm and deaths resulting from power morcellators.
In the fall of 2012, just before Al Gilman's departure, MD Anderson officials cracked down on internal critics.
The Cancer Letter invited Jedd Wolchok, associate attending physician and chief of the Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center, to describe the workings of the just-announced Parker Institute for Cancer Immunotherapy.
A foundation established by Silicon Valley entrepreneur Sean Parker—founder of Napster and first president of Facebook—has committed $250 million to research in cancer immunotherapy.
The Oncology Research Information Exchange Network and M2Gen formed a bioinformatics collaboration with Celgene Corp.
FDA granted permission to an Irish company to market the “PneumoLiner,” a first-of-its-kind containment system indicated for isolating and containing uterine tissue during a minimally invasive hysterectomy or myomectomy. The agency announced its action April 7.
NCI announced a panel of advisors to inform the scientific direction and goals of Vice President Joe Biden's National Cancer Moonshot Initiative.
At a meeting of the NCI Board of Scientific Advisors March 29, NCI officials had good news to report:
The University of Pennsylvania and Genisphere LLC formed a collaborative research agreement to study targeted nanotherapeutics. The collaboration between Genisphere, provider of the 3DNA drug delivery platform, and UPenn’s Theresa Busch, will utilize a breast cancer model to study photodynamic therapy. Photosensitizing drugs are administered to patients prior to surgery, and then activated by visible […]
FDA approved a hepatitis C virus quantitative RNA test to be used as an aid in the diagnosis of HCV infection for certain patient populations.
